<SEC-DOCUMENT>0002045027-25-000003-index.html : 20251204
<SEC-HEADER>0002045027-25-000003.hdr.sgml : 20251204
<ACCEPTANCE-DATETIME>20251204165045
ACCESSION NUMBER:		0002045027-25-000003
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251202
FILED AS OF DATE:		20251204
DATE AS OF CHANGE:		20251204

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Davis Hugh M.
		CENTRAL INDEX KEY:			0002045027
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37581
		FILM NUMBER:		251550388

	MAIL ADDRESS:	
		STREET 1:		C/O ACLARIS THERAPEUTICS, INC.
		STREET 2:		701 LEE ROAD, SUITE 103
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aclaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001557746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				460571712
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		701 LEE ROAD
		STREET 2:		SUITE 103
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
		BUSINESS PHONE:		484-324-7933

	MAIL ADDRESS:	
		STREET 1:		701 LEE ROAD
		STREET 2:		SUITE 103
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-12042025_091242.xml
<TEXT>
Document 1 - file: form4-12042025_091242.html

Document 1 - RAW XML: form4-12042025_091242.xml

</DOCUMENT>
</SEC-DOCUMENT>